RTTNews | Jun 7, 2021 08:14AM EDT

08:14 Monday, June 7, 2021 (RTTNews) - MEI Pharma, Kyowa Kirin Announce First Patient With Marginal Zone Lymphoma Dosed In Expanded Global Phase 2 TIDAL Study

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved